Zhi-Qiang Wang Selected Research

Hydrarthrosis

2/2018	ASIC2a overexpression enhances the protective effect of PcTx1 and APETx2 against acidosis-induced articular chondrocyte apoptosis and cytotoxicity.
1/2018	Interleukin-1β and tumor necrosis factor-α augment acidosis-induced rat articular chondrocyte apoptosis via nuclear factor-kappaB-dependent upregulation of ASIC1a channel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhi-Qiang Wang Research Topics

Disease

64	Neoplasms (Cancer) 01/2022 - 11/2004
27	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 09/2009
22	Neoplasm Metastasis (Metastasis) 02/2021 - 06/2012
18	Stomach Neoplasms (Stomach Cancer) 10/2020 - 10/2010
9	Esophageal Squamous Cell Carcinoma 01/2021 - 06/2012
8	Adenocarcinoma 01/2019 - 09/2009
6	Nasopharyngeal Carcinoma 01/2022 - 08/2016
6	Lymphatic Metastasis 01/2021 - 06/2012
5	Inflammation (Inflammations) 10/2022 - 10/2003
5	Infections 08/2021 - 08/2010
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 07/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 08/2006
4	Carcinoma (Carcinomatosis) 11/2016 - 11/2012
4	Myopathy with Abnormal Lipid Metabolism 07/2016 - 06/2011
3	Melanoma (Melanoma, Malignant) 11/2020 - 05/2009
3	Disease Progression 01/2020 - 12/2006
3	Schizophrenia (Dementia Praecox) 07/2019 - 01/2017
3	Acidosis 01/2019 - 01/2018
3	Rheumatoid Arthritis 10/2018 - 01/2018
3	Hypersensitivity (Allergy) 01/2018 - 01/2010
3	Hemorrhage 04/2017 - 09/2010
3	Multiple Acyl Coenzyme A Dehydrogenase Deficiency 07/2016 - 06/2011
3	Multiple Myeloma 01/2016 - 10/2010
3	Carcinogenesis 12/2015 - 01/2015
3	Pain (Aches) 07/2012 - 06/2004
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 05/2022 - 02/2012
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 01/2021
2	Muscular Diseases (Myopathy) 01/2022 - 01/2016
2	Vomiting 01/2021 - 01/2017
2	Facioscapulohumeral Muscular Dystrophy 01/2021 - 02/2012
2	Nausea 01/2021 - 01/2017
2	Erectile Dysfunction 01/2019 - 02/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2017
2	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 03/2018 - 02/2012
2	Hydrarthrosis 02/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2010
9	Biomarkers (Surrogate Marker)IBA 10/2020 - 02/2013
7	Biological ProductsIBA 01/2022 - 01/2007
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 09/2009
7	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 09/2009
7	EnzymesIBA 01/2018 - 10/2003
7	Messenger RNA (mRNA)IBA 01/2018 - 10/2010
6	Pharmaceutical PreparationsIBA 01/2020 - 11/2008
5	AcidsIBA 10/2018 - 01/2015
5	Carcinoembryonic AntigenIBA 01/2014 - 09/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2013
4	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2016
4	Leucovorin (Folinic Acid)FDA Link 01/2021 - 01/2016
4	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 09/2009
4	ErbB Receptors (EGF Receptor)IBA 01/2019 - 12/2006
4	Cadherins (E-Cadherin)IBA 01/2018 - 06/2012
4	Cetuximab (Erbitux)FDA Link 10/2017 - 01/2011
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 02/2012
3	CateninsIBA 01/2022 - 01/2014
3	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2017
3	Immune Checkpoint InhibitorsIBA 10/2020 - 11/2019
3	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2010
3	LigandsIBA 01/2020 - 06/2004
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 05/2014
3	CytokinesIBA 01/2018 - 06/2004
3	LipidsIBA 01/2018 - 01/2016
3	MicroRNAs (MicroRNA)IBA 01/2017 - 08/2014
3	Therapeutic UsesIBA 02/2013 - 10/2007
3	Superoxide DismutaseIBA 09/2004 - 10/2003
3	Superoxides (Superoxide)IBA 09/2004 - 10/2003
2	Small Interfering RNA (siRNA)IBA 10/2022 - 01/2018
2	UbiquitinIBA 01/2022 - 01/2013
2	InterleukinsIBA 01/2022 - 01/2019
2	nedaplatinIBA 01/2021 - 01/2017
2	toripalimabIBA 01/2021 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 08/2016
2	regorafenibIBA 01/2021 - 01/2020
2	folfirinoxIBA 01/2021 - 01/2019
2	AntibodiesIBA 01/2020 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 10/2019 - 09/2006
2	NADP (NADPH)IBA 07/2019 - 01/2018
2	myocardinIBA 01/2019 - 04/2016
2	NF-kappa B (NF-kB)IBA 01/2019 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2018
2	HDL CholesterolIBA 01/2019 - 08/2016

Therapy/Procedure

25	Therapeutics 01/2022 - 09/2006
24	Drug Therapy (Chemotherapy) 01/2021 - 09/2006
6	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 05/2015
6	Esophagectomy 01/2018 - 05/2014
5	Radiotherapy 01/2020 - 08/2010
4	Hepatectomy 02/2021 - 10/2017
4	Immunotherapy 01/2021 - 01/2018
4	Gastrectomy 01/2019 - 02/2011
3	Length of Stay 01/2022 - 03/2015
3	Induction Chemotherapy 10/2021 - 01/2019
3	Salvage Therapy 01/2021 - 09/2009
3	Metastasectomy 01/2019 - 01/2017
3	Thoracotomy 01/2018 - 11/2016
3	Adjuvant Chemotherapy 01/2017 - 01/2014
2	Chemoradiotherapy 01/2022 - 01/2019
2	Kidney Transplantation 08/2021 - 12/2016
2	Intravenous Infusions 08/2021 - 01/2019
2	Re-Irradiation 01/2021 - 08/2016
2	Solid-State Lasers 11/2020 - 06/2014
2	Operative Surgical Procedures 05/2018 - 11/2017